Gefitinib or erlotinib for previously treated lung adenocarcinoma: Which is superior?

Chia Hao Chang, Chih Hsin Lee, Jann Yuan Wang

研究成果: 雜誌貢獻快報同行評審

5 引文 斯高帕斯(Scopus)

指紋

深入研究「Gefitinib or erlotinib for previously treated lung adenocarcinoma: Which is superior?」主題。共同形成了獨特的指紋。